Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Cocaine addiction, craving and relapse

  • On-demand X-rays at synchrotron light sources

  • How racial stereotypes impact the way we communicate

  • Breakthrough measures Parkinson's progression in brain

  • Study identifies possible role for carbon monoxide in treating hemorrhagic stroke

  • Moderate drinking in later years may damage heart

  • Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies

  • Study examines association of genetic variants with cognitive impairment

  • Hospice use linked to fewer depressive symptoms for surviving spouses

  • Where there's a will ? well, there's another way

  •